Table 2.
Self-reported non-injection drug use characteristics, drug treatment program history, and urine toxicology results (n = 97).
| Non-injectors (n = 50) |
Injectors (n = 47) |
Injectors vs Non-injectors | |||||
|---|---|---|---|---|---|---|---|
| Variable | HIV− (n = 14) | HIV+ (n = 36) | P | HIV− (n = 35) | HIV+ (n= 12) | P | P |
|
| |||||||
| Self-reported NID use | |||||||
| NIDs used in the past year | 6 (43%) | 14 (39%) | 0.7466 | 27 (77%) | 7 (58%) | 0.2687 | 0.0020 |
| Alcohol | 6 (l00%) | 13 (93%) | >0.9999 | 20 (74%) | 5 (71%) | >0.9999 | 0.0719 |
| Marijuana | 0 (0%) | 4 (29%) | 0.2675 | 9 (33%) | 1 (14%) | 0.6445 | 0.5326 |
| Crystal meth | 0 (0%) | 4 (29%) | 0.2675 | 13 (48%) | 2 (29%) | 0.4263 | 0.0862 |
| Cocaine | 1 (17%) | 4 (29%) | >0.9999 | 13 (48%) | 3 (43%) | >0.9999 | 0.1511 |
| Downers | 0 (0%) | 0 (0%) | >0.9999 | 5 (19%) | 1 (14%) | >0.9999 | 0.0740 |
| MDMA/ecstasy | 0 (0%) | 0 (0%) | >0.9999 | 7 (26%) | 1 (14%) | >0.9999 | 0.0201 |
| Heroin | 1 (7%) | 0 (0%) | 0.3000 | 1 (4%) | 1 (14%) | 0.3845 | >0.9999 |
| Xylazine | 0 (0%) | 0 (0%) | >0.9999 | 4 (15%) | 0 (0%) | 0.5585 | 0.2845 |
| Buprenorphine | 6 (100%) | 5 (36%) | 0.0141 | 9 (33%) | 2 (29%) | >0.9999 | 0.1521 |
| # NIDs used | 2 (0) | 2 (1.75) | 0.4989 | 3 (2) | 2 (2) | 0.3515 | 0.2407 |
| Drug treatment history | |||||||
| Ever | 0 (0%) | 12 (33%) | 0.0215 | 30 (86%) | 11 (92%) | >0.9999 | <0.0001 |
| In the past year | 0 (0%) | 3 (25%) | >0.9999 | 18 (60%) | 9 (82%) | 0.2753 | 0.0195 |
| Urine toxicology | |||||||
| Urine test positive | 2 (14%) | 28 (78%) | <0.0001 | 34 (97%) | 11 (92%) | 0.4496 | <0.0001 |
| Multidrug positive | 0 (0%) | 15 (54%) | 0.4828 | 28 (82%) | 7 (64%) | 0.2279 | 0.0233 |
| Fentanyl | 0 (0%) | 0 (0%) | >0.9999 | 21 (62%) | 4 (36%) | 0.1757 | <0.0001 |
| Cocaine | 0 (0%) | 6 (21%) | >0.9999 | 19 (56%) | 5 (45%) | 0.7302 | 0.0044 |
| Opiates | 0 (0%) | 0 (0%) | >0.9999 | 15 (44%) | 4 (36%) | 0.7363 | <0.0001 |
| Benzodiazepines | 0 (0%) | 13 (46%) | 0.4920 | 10 (29%) | 2 (18%) | 0.6991 | 0.1444 |
| Methadone | 0 (0%) | 2 (7%) | >0.9999 | 18 (53%) | 7 (64%) | 0.7295 | <0.0001 |
| Marijuana | 2 (100%) | 13 (46%) | 0.4828 | 13 (38%) | 3 (27%) | 0.7202 | 0.2393 |
| TCAs | 0 (0%) | 5 (18%) | >0.9999 | 6 (18%) | 0 (0%) | 0.3111 | 0.7461 |
| Amphetamine | 0 (0%) | 2 (7%) | >0.9999 | 5 (15%) | 0 (0%) | 0.3131 | 0.6952 |
| Oxycodone | 0 (0%) | 1 (4%) | >0.9999 | 0 (0%) | 0 (0%) | >0.9999 | 0.4000 |
| Barbiturates | 0 (0%) | 1 (4%) | >0.9999 | 0 (0%) | 0 (0%) | >0.9999 | 0.4000 |
| Buprenorphine | 0 (0%) | 1 (4%) | >0.9999 | 0 (0%) | 4 (36%) | 0.0022 | 0.6424 |
| # positive drugs in urine | 0 (0) | 1 (1) | <0.0001 | 3 (2) | 2 (2.5) | 0.2390 | <0.0001 |
Continuous variables are shown as median with interquartile range and compared using Mann-Whitney tests. Categorical data are shown as counts with percentages (%) and compared using Fisher’s exact tests. The P values are italicized and significant P values are bolded.
NID, non-injection drug; TCA, tricyclic antidepressant.